title: Perioperatory pain in oncological patient - physiopathological and therapeutical implications.
abstract: Perioperatory pain in oncological patients represents a witness of anesthetic-surgical aggression, frequently exacerbated by the complementary radio-chemotherapy and also a predictive factor for postoperatory evolution. The objectivation of perioperative pain by scales of clinical evaluation does not offer a certain and objective quantification; so, the dosing of some hormonal and acute phase inflammation mediators could realize a more realistic projection. Clinical and biological correlation can offer a support for an adequate and well-balanced treatment.
authors: Anaesthesia and Intensive Care Unit, Oncological Institute Bucharest.
authors: C
authors: C
authors: Diaconu
authors: Anaesthesia and Intensive Care Unit, Oncological Institute Bucharest.
authors: C
authors: C
authors: Pantis
authors: Surgery Clinic No. 1, Oncological Institute Bucharest.
authors: C
authors: C
authors: Cirimbei
authors: Surgery Clinic No. 2, Oncological Institute Bucharest.
authors: C
authors: C
authors: Bordea
authors: Surgery Clinic No. 2, Oncological Institute Bucharest.
authors: A
authors: A
authors: Blidaru
mesh_terms: D016718:Arachidonic Acid / Q000378:metabolism; D002570:Ceruloplasmin / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000601:surgery*; D010146:Pain / Q000209:etiology* / Q000503:physiopathology*; D059408:Pain Management; D019990:Perioperative Care
chemical_list: D016718:Arachidonic Acid; D002570:Ceruloplasmin
keywords: hormones; inflammatory mediators; multimodal treatment; perioperatory pain